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Abstract
Background: The management of medicines towards the end of life can place increasing burdens and responsibilities
on patients and families. This has received little attention yet it can be a source of great difficulty and distress patients
and families. Dose administration aids can be useful for some patients but there is no evidence for their wide spread
use or the implications for their use as patients become increasing unwell. The study aimed to explore how healthcare
professionals describe the support they provide for patients to manage medications at home at end of life.
Methods: Qualitative interview study with thematic analysis. Participants were a purposive sample of 40 community
healthcare professionals (including GPs, pharmacists, and specialist palliative care and community nurses) from across
two English counties.
Results: Healthcare professionals reported a variety of ways in which they tried to support patients to take medications
as prescribed. While the paper presents some solutions and strategies reported by professional respondents it was
clear from both professional and patient/family caregiver accounts in the wider study that rather few professionals
provided this kind of support. Standard solutions offered included: rationalising the number of medications; providing
different formulations; explaining what medications were for and how best to take them. Dose administration aids
were also regularly provided, and while useful for some, they posed a number of practical difficulties for palliative care.
More challenging circumstances such as substance misuse and memory loss required more innovative strategies such
as supporting ways to record medication taking; balancing restricted access to controlled drugs and appropriate pain
management and supporting patient choice in medication use.
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Conclusions: The burdens and responsibilities of managing medicines at home for patients approaching the
end of life has not been widely recognised or understood. This paper considers some of the strategies
reported by professionals in the study, and points to the great potential for a more widely proactive stance
in supporting patients and family carers to understand and take their medicines effectively. By adopting
tailored, and sometimes, ‘outside the box’ thinking professionals can identify immediate, simple solutions to
the problems patients and families experience with managing medicines.
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Dose administration aids
Background
Professional focus on medicine prescribing and adherence
has sometimes been accompanied by a lack of awareness of
the concerns which patients frequently have about their
medicines, and the burden and practical difficulties involved
in taking them [1]. Notenboom et al. [2] demonstrate some
of the pragmatic challenges patients face when charged with
managing medications in the home. Study participants cited
211 problems with using oral prescription medications, with
95% of participants identifying at least one issue. Participants
reported employing 184 strategies to manage these practical
problems. Seventeen percent of participants experienced a
medication issue that led to clinical deterioration. The partic-
ipants in the study identified a range of issues around reading
and understanding the instructions for use (also see [3]), dif-
ficulties handling packaging, and physical issues around tak-
ing medicines [2].
In the UK guidelines have been developed for professionals
that focus on involving patients and their family members in
decisions about medications and prescribing [4]. Alsaeed
et al.’s [5] literature review highlights a number of areas in
which healthcare professionals (HCPs) could help to improve
patients’ medicines management at home. While the focus
of the review was on patients with dementia and their care-
givers, many of their recommendations are more broadly ap-
plicable. Good communication, between patient and family
caregiver (FCG), between families and HCPs, and between
HCPs is fundamental to identifying and managing any issues
with medication [6]. Providing clear information about medi-
cations and undertaking regular reviews were also central el-
ements that promote and support medicines management
[5] (also see [1]). There are a number of dose administration
aids [see Fig. 1] and technologies available for patients and
FCGs to support management and administration. Multi-
compartment compliance aids can be extremely useful for
some but do have a number of limitations [7, 8] and there is
currently insufficient evidence to support their widespread
use [4, 9, 10].
Research into older age, including the impact of de-
mentia, is contributing to our knowledge about the role
patients and FCGs must take on in order to manage
medications [1, 2, 11, 12]. This work has identified that
patients often have to cope with complex regimes and
require considerable support from FCGs. Managing
Fig. 1 Dose administration aids
Wilson et al. BMC Palliative Care           (2020) 19:66 Page 2 of 10
medications when someone is seriously ill and dying at
home can generate additional issues. However, little at-
tention has been paid to the context of palliative and
end of life care. As patients become increasingly unwell,
they often require frequent and irregular changes to
their medication regimes. This may include stopping
some long-term preventative medicines such as statins,
but increasing others such as those for pain and nausea
(see Figure 2 on Polypharmacy and deprescribing [13–18]).
Patients may begin to struggle with swallowing standard
tablets and medications may be dispensed in other forms
such as patches, liquids or sublingually. There is increasing
evidence that family caregivers experience a number issues
in adjusting doses and responding to rapid drug changes to
control difficult and distressing symptoms in the period
leading up to the patient’s death [19].
Methods
Study design
Qualitative study underpinned by a social constructionist
perspective involving semi-structured in-depth inter-
views. Interviews were situated accounts of HCPs’ per-
spectives and understanding. In their different roles
HCPs engage with patients and families in a variety of
ways, in clinics, pharmacy/community settings and in
their own homes allowing them to identify practical day-
to-day issues and offer support. This paper draws on a
set of findings from a wider NIHR funded UK study to
explore the management of medications for patients
who are approaching end of life. We report on how
HCPs described the way in which they supported pa-
tients and families to manage medications in their
homes. Patient and family perspectives will be reported
elsewhere.
Setting
The study is set in two English counties. Both are di-
verse in levels of affluence, age, ethnicity and population
density, with both rural and urban areas. In both regions
there are generalist and specialist teams providing pallia-
tive and end of life care.
Participants
Participants included 40 community professionals from a
range of roles, including: General practitioners (GP), spe-
cialist palliative care nurses, community nurses and both
GP- and community-based pharmacists (see Table 1). Par-
ticipants were recruited using purposive and snowballing
techniques across the two counties via GP practices, spe-
cialist palliative care services and via email to a number of
key contacts who were asked to distribute the information
to their networks.
Data collection and recording
Interviews took place between June 2017 and October
2018. The majority of participants were interviewed indi-
vidually at their place of work and during work hours.
However, we were receptive to workload constraints and
participant preferences so undertook four interviews
over the telephone, one joint interview, and three group
interviews (involving three or more participants). Inter-
views lasted between 19 and 69 min. All participants
gave written or, in the case of telephone interviews, ver-
bal consent. An interview schedule was used as a guide
allowing the flexibility to tailor and adapt each interview
to the participant and their responses. All interviews
were audio recorded and notes written up after the
interview took place. The focus of the interviews was to
explore what HCPs saw the issues to be for patients and
families managing medications at home as the patient
approached the end of life, and how they sought to sup-
port such patients and families in managing their medi-
cations. HCPs were asked to think of a current or recent
case which had posed issues for medicines management
or where this had worked well. They were then asked to
situate this case within their normal practice to establish
how common or rare particular issues might be. The
interview guide can be found in Appendix A. All inter-
views were conducted by EW, GC and KP. All have
Fig. 2 Polypharmacy and deprescribing
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considerable training and experience in sensitive topics,
qualitative methods and palliative and end of life care.
Analysis
All interviews were transcribed verbatim and fully anon-
ymised before transcripts were uploaded to Nvivo12©
and coded. Using a process of thematic analysis EW, GC
and KP reviewed codes and undertook condensing and
sorting. The legitimacy of categories was reviewed with
the project steering group and considered in the context
of the data collection methods. Several transcripts were
also read and coded by our PPI co-applicant (Alan Cas-
well) for an additional perspective, transparency and
comparison. Each transcript was coded by two team
members and three were triple coded. Once coding was
complete, nodes were further interrogated and refined to
generate node summaries of key themes illustrated by
quotations from transcripts. A number of key findings
emerged during this process. These have also been com-
pared with patient, family caregiver and bereaved family
caregiver finding as part of the wider study. In June 2019
findings were presented at two workshops for HCPs
(some of whom participated in the interviews) for feed-
back and comment. This paper focuses on the ways in
which HCPs reported supporting patients and families
to manage medications in the home.
Results
The majority of HCPs in this study acknowledged that
patients did not always take medications as prescribed
and many reported trying to explore how to resolve this
with patients and families. Dosette boxes, and more
commonly ‘blister packs’, were prepared by pharmacists,
and often delivered directly to patients’ homes. These
were offered and perceived as a problem solving inter-
vention to help patients to organise and remember when
to take their medicines. In a number of cases these
boxes could be helpful and appropriate. However, HCPs
recognised that some patients and families needed more
comprehensive and innovative approaches. Here we dis-
cuss the strategies reported by HCP participants, includ-
ing some who described ways of thinking ‘outside the
box’ in order to help support patients overcome the
practical difficulties of managing their medications in
the home environment. Awareness of the challenges
faced by patients and family caregivers was not evident
in all professional accounts as is illustrated in this insight
from a community nurse in her explanation of the
underpinning issues:
It is very difficult for patients and I think, as health-
care professionals, sometimes, we can be a little bit
blasé about writing prescriptions and not realising …
the impact that will have [for the patient] at home
when they’re faced with their twenty pills in the
morning, and they’ve got to work out which one to
take off, and which one to put back on, and obvi-
ously, we produce changes, they get used to the little
round white one then it turns blue, and they don’t
know what’s going on. So, I think it’s very important
that when we’re prescribing, we spend an appropri-
ate amount of time making sure that people under-
stand what we’ve given them, what it’s for, what we
expect it to do, but also, think about, … you’re in the
home environment … you can check for the last six
months’ stockpile that’s in the kitchen cupboard and
things like that, to help people out. (HCP19_Com-
munity nurse).
In general, HCPs/ HCPs tended to focus on prescrib-
ing issues, rather than express awareness or curiosity
about patient perspectives and experience of medicine
taking. Some seemed resigned to deliberate or inadvert-
ent failure on the part of patients to take medication as
prescribed.
I’ve got a lady at the minute …, she’s probably on
twenty three medications. You go in [to her house
and look at her medication boxes] ‘oh great, they’re
taking all the medication’, and then you look on the
floor, and you see there’s pills all over the place. So, I
don’t delude myself that any of them are taking
medications as prescribed. (HCP05_Community
Nurse).
As the GP in the following quote indicates, a simple
response of writing out a guide to a patient’s medication
Table 1 Participants by profession
Role Number of participants
Specialist palliative care nursesa 15
Community nursesb 12




aSpecialist palliative care nurses – those working at a Band 6 or 7 level with
additional training in palliative care. These may include: Clinical Nurse
Specialists/Hospice at home nurses – these nurses provide advice and support
to patients and families as well as having expertise in the management of
symptoms. They may be assigned to work in patients’ homes or with care
homes. Macmillan Nurses – some specialist palliative care nurses are badged
under the brand of ‘Macmillan Cancer Support’, a national cancer charity.
These nurses focus on providing advice for the management of complex
symptoms and/or psychological distress
bThis is an overarching group of nurses working in the community including
District nurses, Community Matrons and Clinical Nurse Specialists in non-
palliative specialisms such as heart failure and neurological conditions. In the
UK, qualified nurses’ start at Band 5 and go up to Band 8. Nurses at Band 6
have advanced training, skills and experience; those at Band 7 have
managerial roles in addition
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was not something they had done before nor intended
to do again, despite the apparent benefits for the patient.
They also note that the patient had to present to them
in some considerable distress to prompt this option:
So she came to see me in a complete sort of melt-
down once, being just very upset and ... didn’t have
any sort of memory about how to take her medica-
tions at all … that was just due to being very worked
up I think rather than anything else going on. And I
wrote down, I gave her a little sheet that said take
this at this time in this dose basically, typed that out
for her. And … she doesn’t want to give up her inde-
pendence, it’s very, very important to her, so not be-
ing able to manage her own medications is for her a
disaster … Yeah, she brought it back and showed me
and said I’m using this now thank you. I’ve never
done that for anyone else before. … That’s the only
person I’ve ever done that for and it was only be-
cause she was so distressed by it and it is this unique
set of circumstances. (HCP25_GP).
Effectiveness and challenges of well established solutions
to medicines management
Dosettes and blister packs were often seen as an effective
strategy in eliminating any confusion about what tablets
to take when. HCPs viewed them as an important tool
and appropriate way to support patient’s wishes to con-
tinue to manage at home independently. A few respon-
dents observed that this system was sometimes put in
place for the convenience of paid Home Care Workers en-
listed to prompt patients to take medication in the home,
rather than the patient. However, this could potentially
undermine agency and competence, detaching patients
from the process by ‘making people further removed from
taking responsibility of their own medication’ (HCP05_
Community nurse). They also made it difficult, if not im-
possible, for patients to identify individual tablets.
Dosette boxes and blister pack were recognised to
pose two key issues for palliative care. One is that they
do not accommodate all types of medication. Conse-
quently, patients might have to take additional medica-
tions, such as liquids or tablets prescribed to be taken ‘as
needed’, alongside the allocated pills from the box. Sec-
ondly, box contents are usually made up for a month,
and cannot be easily altered if medication is changed
during this period. HCPs also identified potential prob-
lems with pain medications where patients who are un-
aware of, or unable to identify the contents, may risk
taking more pain relief than they need if they are also
taking ‘as needed’ doses on top of those included in their
dosette box.
And I think actually pain does vary day to day in a
patient, what they do or are not doing. And I’m very
hesitant actually to put it in dosette boxes as well
for that reason. And also, if you do get side effects,
you get more drowsy for any other reasons, you really
want to reduce this quickly and not taking the next
dose and so forth. So you don’t have this variety, be-
cause in a dosette box I can’t, most of the time, see
which of the pills is which, let alone the patient, and
you can’t take it out and then say, ‘Ooh I think I’d
better miss that because I’m feeling drowsy’.
(HCP25_GP).
Some healthcare professionals recognised the limitations
of the pre-prepared dosette box for patients at the end of
life and the differing needs of individual patients. Review-
ing and rationalising medications was often seen as the
first step to supporting effective medicines management.
HCPs, especially nurses making home visits, recognised
that a number of issues with medications stemmed from
patients not fully understanding what their medications
were, what they were for, and how they should be taken.
However, they also noted despite the involvement of mul-
tiple health professionals few took responsibility for over-
arching management of medications and many often did
not ask the right questions or investigate the underlying
causes of patients’ issues with medication:
I suppose we always think that the pharmacists are
doing a lot of the explaining and a lot of the discus-
sion … [but] I’ve never really had that conversation
with a pharmacist and saying, Actually, do you just
give them the Morphine, or do you tell them any-
thing else? (HCP11_GP).
He was like a rabbit in the headlights, he didn’t
know what to do, he’d just got all these tablets there,
he didn’t know what to do, he didn’t understand
what half of them were for. So his way was to not
take them, … and people were going along the lines
of, ‘oh those, those medicines haven’t worked, let’s try
something else’, but actually, those medicines had
never been taken. … And nobody had taken the time
to discuss it with him. (HCP14_Specialist Palliative
Care nurse).
This was a particular issue when changes were made
to medication regimes, as is common in end of life care.
For these issues, taking some time to explain, and imple-
menting a simple memory aid system to support the ex-
planation, could be extremely effective.
So I give [out] a lot of laminated prompt cards, that
just lays out, you know,’ your aspirin is being taken
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for this, it should be taken with food in the morning’,
and then they can follow that. And that actually
helps way more than a dosette (HCP21_Pharmacist).
HCPs also reported using items such as lockable tins
for patients who could not safely manage their own
medications, or where there was potential for misuse or
misappropriation of medication, and dispensers with
timing devices or alarms for those with impaired mem-
ory. Some reported changing the route of administration
for a patient when swallowing tablets became an issue or
when the number of tablets added to the burden of
medicines management. One community nurse felt al-
ternative administration routes also supported adherence
as they did not hold the same negative connotations as
‘pills’ and ‘tablets’. Yet HCPs also noted that patients
and families did not always know that medication came
in different formulations or that they could request this.
Actually, a lot of relatives and patients aren’t aware
they can change the form of the medication and
have something that’s either dispersible or in liquid
form. … as I’m doing my nursing assessment, I’ll talk
about medication as one of the things I’m discussing.
And, so I’m saying, ‘Are you managing to swallow
your medication okay?’ At that point, unless they
were asked a direct question, patients don’t often flag
it up to you, so, largely, ‘no’. ‘It takes me half an
hour in the morning, to swallow one tablet’. And
they don’t realise, actually something simple like
putting it in some yogurt and having it as a bolus,
might help it, help swallow it, or they won’t realise
that, actually, that type of medication, you can have
in a different form and have it in a syrup.
(HCP06_Community nurse).
Thinking outside the (dosette) box
Participants described cases where they had needed to
take a more innovative and active role in supporting the
patient to manage medications.
I had a gentleman who couldn’t read or write, …
and he lived on his own, what we ended up doing
with him, with managing his medicines, was taking
one of the medicines, [sticky] taping it to a piece of
paper and saying this one, and then writing next to
it, like, how many times a day to take it, so three
dashes …. you learn little ways of, often, you try
something, that doesn’t work so you try something
else, so it is tricky. (HCP14_Community nurse).
In a small number of reported instances, HCPs recog-
nised that their input was needed on a more consistent
basis to support medication use. A few HCPs reported
telephoning patients to remind them of recent
changes to their medications. One HCP narrated an
instance with a patient with memory issues who was
repeatedly coming to hospital with heart failure symp-
toms because he was not remembering to take his
medication. They subsequently rationalised this to be
taken once a day and arranged for a community
nurse to visit daily to prompt this administration.
However, lack of time to adequately discuss and
monitor medicines and related issues was acknow-
ledge to be a limitation. This level of input was un-
likely to be routinely available and the HCP who
recounted this experience also noted that this was an
‘extreme’ response that could not be support for long.
Tailored solutions were particularly required in diffi-
cult and unusual situations, for example where patients
or someone in their household were affected by phobias,
addictions, substance abuse or the effects of dementia.
One palliative care nurse described how she and her col-
leagues were working to find constructive and creative
ways to manage pain for a patient who was determined
to die at home. As the patient, his FCG and their circle
of friends had issues with substance misuse, safeguards
were put in place to limit the amounts of morphine they
could access at any one time.
We just introduced the patch last week, he was using
a lot of the Oramorph, … he’s used the Oramorph
less since the patch has gone on. … We always put
dates on the bottle and the box. So we can see which
bottle he’s still using and which box, and keep an
eye on it as well. He knows we do that. (HCP07_Spe-
cialist Palliative Care nurse).
This HCP also recalled a patient who expressed a fear
of needles and refused any injectable medications. In the
quote below the HCP described trying to balance re-
specting the patient’s choice and agency and providing
effective care:
We can’t use needles. So we are limited in what
medication he can have to manage his symptoms
anyway. We’ve got patches … And we’ve got buccal
things that we can use to manage as much as we
can, but obviously, it doesn’t give us the range that
we would normally have. (HCP07_Specialist Pallia-
tive Care nurse).
Recognition, and support for, patient choices about
their treatment and care was a strong theme throughout
the interviews. A number of HCPs described the consid-
erable effort they were prepared to make to enable these,
regardless of whether they considered them to be wise
options.
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So she’d developed swallowing issues. And so we
tried liquid medication, she didn’t like it. … So she
went back to taking oral tablets. … And then I can
think about an incident, it was interesting, at the
hospice, where I got a phone call from the staff nurse
saying the carers had said that she’d had a choking
episode following taking tablets in the morning, and
that, at the hospice, they weren’t going to be pre-
pared to give her tablets any longer. … I said, ‘This
isn’t an issue, this lady has capacity to make the de-
cision, she doesn’t want to take liquid medication,
she wants to take her tablets, the risks have been ex-
plained to her’. (HCP05_Community nurse).
There were few references to pharmacists taking on
roles to support medicines management or to other
HCPs identifying the potential for greater pharmacy in-
tegration in the healthcare team.
Discussion
Patients living at home at the end of life often have com-
plex medication regimes with large numbers of medica-
tions, different routes of administration, and high doses
of controlled drugs. In line with the international litera-
ture, the HCPs participating in this study recognised the
burdens of polypharmacy at end of life [14, 16, 20–22],
but did not always seem to acknowledge how the bur-
dens of medication management added to the ‘work’ pa-
tients and FCG’s were undertaking when someone is
seriously ill in the home environment [23]. FCGs are
also more likely to be older, and have reduced abilities
and co-morbidities of their own [24]. Until recently
much of the literature on medication management fo-
cused on ‘adherence’ and ‘compliance’ and the implica-
tion for health outcomes [5, 25–28]. There is now a
small but growing body of work that recognises the diffi-
culties for patients [2], their desire to limit the amount
of medications they take as far as possible [16, 29, 30]
and the burdens regimes can place on FCGs when a pa-
tient is dying at home [19, 21, 31]. Indeed, the inter-
national literature indicates that in other countries,
particularly the United States and Australia, FCGs are
regularly undertaking even more advanced tasks in ad-
ministering sub-cutaneous medications prescribed for
end of life symptoms [32–36]. While there have been
some moves towards this in the UK the feasibility of this
approach is still being assessed [37, 38].
This paper has explored ways in which HCPs in a UK
study reported on well established solutions to medi-
cines management and more innovative ‘outside the box’
thinking in order to support patients and families with
medication needs. Some expressed resignation that pa-
tients often failed to, could not or did not want to take
their medications as prescribed. Not all HCPs recognise
that a strategy of verbal explanation on its own was not
always effective in helping patients to understand and
manage their medications, particularly at the end of life.
Accounts, particularly from specialist palliative care
nurses, noted that when multiple health professionals
were involved there was little coordination or designated
responsibility for medications management. HCPs in this
study often focused on the prescription element of the
process, aiming to ensure appropriate symptom control
by undertaking simple changes to regimes and routes of
administration. However, while these may present as ob-
vious and standard initial options not all HCPs in the
study thought to implement them. These adaptations
often made a considerable difference to patients’ ability
to manage their medicines effectively. In other instances,
HCPs reported having to be quite innovative, and ex-
plore a number of routes to help patients overcome the
practical problems involved in organising and taking
their medicines effectively.
While not aimed specifically at palliative care, current
UK guidance [17, 39] advocates for professionals to take
account of individual patient needs, preferences for
treatment, health priorities and lifestyle and recognise
that ‘medicines are likely to be just one aspect of a per-
son’s care’ [39]. However, to date there has been little
work to explore ways of supporting patients and families
in medicines management in order to make their lives
less stressful [4, 40].
The ability to maintain accurate medicine taking could
be a critical factor in avoiding unscheduled hospital ad-
missions and determining whether a patient could re-
main living at home [41–43]. This paper seeks to extend
beyond the compliance/adherence discourse [44] to rec-
ognise the reasonable difficulties patients and families
often face in managing complex regimes and how HCPs
play a proactive role in helping them overcome these
[5]. HCPs in this study often reported encouraging the
use of simple dose administration aids such as dosette
boxes and blister packs. These can be extremely useful
and can support patients to remain at home by helping
them to manage their own medication. They can also be
a useful tool in supporting Home Care Workers to safely
prompt and administer medications in patients’ homes
[7–9, 45]. Conversely, these aids can have negative im-
plications for a person’s independence and agency when
they disempower patients by removing responsibility for,
and understanding of, their own medications [46]. They
also have practical disadvantages when, as is common in
end of life care, medications need to be changed rapidly
and frequently [7]. This increases risk of adverse events,
lack of effective symptom management, and instability
of some medications when stored outside their original
packs. These types of issues add to the challenge of opti-
mising pain control in the home environment [47, 48].
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This paper has demonstrated that there is scope for
much greater understanding of the reality of patient and
FCG experience, the difficulties they face, and the poten-
tial for HCPs to engage with innovative and tailored
ways of supporting medicines management for seriously
ill patients being cared for and dying at home. Our find-
ings further echo those of current literature in that the
majority of participants rarely recognised the current or
potential contribution of pharmacists as part of the pal-
liative care team [49–54].
Limitations
A strength of the study is that it represents the views of a
wide range of HCPs, including pharmacists, working in di-
verse community healthcare services and geographic loca-
tions. However, the study location in two adjacent English
counties means that the findings may not be typical of other
settings. It is also important to note that 17/40 participants
were considered to be specialists in palliative care and 4/40
condition specific specialists. As such, we would expect them
to manage a more complex caseload and be able to imple-
ment a wider range of ways to support patients in managing
their medications. We recognise that as self-selected partici-
pants, they are likely to have an interest and specialist expert-
ise in the management of medications. Interviews may
involve accounts in which respondents are likely to be moti-
vated to give a good account of their practice. We are unable
to know how this compares with what they actually do in
practice. However, data from patients and FCGs in other
parts of the study suggest that proactivity by HCPs is far
from routine and especially in the last weeks and days of life
when families are confronted with real anxieties about the
management of medications.
Conclusions
If we move the discourse forward from one of compli-
ance and adherence and recognise the reasonable, and
often practical, difficulties patients and FCG face when
managing medications we can look at ways in which
HCPs can help them to overcome these issues. Medica-
tion reviews, reduction of problematic polypharmacy
and the use of dose administration aids such as dosette
boxes are some of the established ways in which HCPs
can support patients and families in medicines manage-
ment at the end of life. However, there may be times
when HCPs need to ‘think outside the box’ in order to
identify and support patients to safely, effectively and in-
dependently manage their medications.
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